Cargando…

Clusterin transduces Alzheimer-risk signals to amyloidogenesis

Detalles Bibliográficos
Autores principales:	Liu, Xi, Che, Rongbo, Liang, Wenping, Zhang, Yun, Wu, Liyong, Han, Chao, Lu, Hong, Song, Weihong, Wu, Yili, Wang, Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499966/ https://www.ncbi.nlm.nih.gov/pubmed/36138003 http://dx.doi.org/10.1038/s41392-022-01157-x

Ejemplares similares

KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer’s disease models
por: Lee, Do Yeon, et al.
Publicado: (2017)

Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice
por: Ham, Hyeon Joo, et al.
Publicado: (2019)

Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)
por: Zhao, Y, et al.
Publicado: (2015)

Cofactor-mediated amyloidogenesis
por: Madine, Jillian
Publicado: (2019)

Microbiome Impact on Amyloidogenesis
por: Seira Curto, Jofre, et al.
Publicado: (2022)

The effects of resistance exercise on cognitive function, amyloidogenesis, and neuroinflammation in Alzheimer’s disease
por: Azevedo, Caroline Vieira, et al.
Publicado: (2023)

No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
por: Silajdžić, Edina, et al.
Publicado: (2012)

Modulating the Amyloidogenesis of α-Synuclein
por: Sivanesam, Kalkena, et al.
Publicado: (2016)

Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors
por: Guo, Xiaohua, et al.
Publicado: (2020)

Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
por: Di Fede, Giuseppe, et al.
Publicado: (2016)

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
por: Tang, Lian, et al.
Publicado: (2022)

Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
por: Ling, I-Fang, et al.
Publicado: (2012)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023)

Discovery of γ-Mangostin as an Amyloidogenesis Inhibitor
por: Yokoyama, Takeshi, et al.
Publicado: (2015)

A molecular mechanism for transthyretin amyloidogenesis
por: Yee, Ai Woon, et al.
Publicado: (2019)

Amyloidogenesis and Neurotrophic Dysfunction in Alzheimer’s Disease: Do They have a Common Regulating Pathway?
por: Jiao, Fengjuan, et al.
Publicado: (2022)

A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
por: Catania, Marcella, et al.
Publicado: (2022)

Phytochemical Interactions with Calmodulin and Critical Calmodulin Binding Proteins Involved in Amyloidogenesis in Alzheimer’s Disease
por: O’Day, Danton H.
Publicado: (2023)

Alzheimer's risk variants in the clusterin gene are associated with alternative splicing
por: Szymanski, M, et al.
Publicado: (2011)

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
por: Weinstein, Galit, et al.
Publicado: (2016)

Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer’s Disease
por: Chen, Ping, et al.
Publicado: (2013)

Functional Amyloidogenesis and Cytotoxicity—Insights into Biology and Pathology
por: Fowler, Douglas M., et al.
Publicado: (2012)

Prediction and Analysis of Antibody Amyloidogenesis from Sequences
por: Liaw, Chyn, et al.
Publicado: (2013)

Plasminogen activation triggers transthyretin amyloidogenesis in vitro
por: Mangione, P. Patrizia, et al.
Publicado: (2018)

Clusterin confers gmcitabine resistance in pancreatic cancer
por: Chen, Qingfeng, et al.
Publicado: (2011)

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
por: Wang, Xin, et al.
Publicado: (2017)

Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2014)

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer’s Biomarker
por: Islam, Kamrul, et al.
Publicado: (2018)

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019)

Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
por: Bradley, David
Publicado: (2020)

Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection
por: Bungon, Theodore, et al.
Publicado: (2021)

Correction: Clusterin confers gemcitabine resistance in pancreatic cancer
por: Chen, Qingfeng, et al.
Publicado: (2013)

Amyloidogenesis Abolished by Proline Substitutions but Enhanced by Lipid Binding
por: Jiang, Ping, et al.
Publicado: (2009)

Amyloidogenesis of SARS-CoV-2 Spike Protein
por: Nyström, Sofie, et al.
Publicado: (2022)

The role of α-sheet structure in amyloidogenesis: characterization and implications
por: Prosswimmer, Tatum, et al.
Publicado: (2022)

Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022)

Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis
por: Deng, Jun, et al.
Publicado: (2021)

Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway
por: Gu, Sun Mi, et al.
Publicado: (2018)

Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy
por: Solovyev, Nikolay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jtq6vo03tsos1k3t6la8tpc2sb